Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease.
about
Iron dysregulation in Huntington's diseaseActivators of G protein signaling exhibit broad functionality and define a distinct core signaling triadPossible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's diseaseReinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion.Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.Rhes suppression enhances disease phenotypes in Huntington's disease micePreclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.mTOR in Brain Physiology and Pathologies.
P2860
Q26829932-ECCB494A-23D1-477D-AA1B-9E920B1AE4EBQ26999408-2A598B6A-D8C0-4293-9CFF-1540F65A8EA7Q27011417-930FCBEC-17C1-453F-AD78-C88C8B24932FQ27306293-3F507D90-15FE-4995-B21D-0CC24F508834Q30658223-E05A5E6A-7C48-4449-8D53-685F5FF6A980Q33831774-4120A3EE-7234-48E2-A48B-43C8BB776079Q34071922-DCDD17EF-0DF4-4572-8BD8-A8A665466A1AQ34284039-2E07C606-5356-43BB-8E5D-923147DF8B52Q37241010-30D06220-4307-454A-9826-52B83DC0DB28Q37482165-2774BEE5-9742-4A8D-8C95-45D4CBBA7C40Q37563505-DED596DD-B782-415F-AE78-C059D5D4DEDBQ38447132-37D884C1-DBC2-4032-B798-25E997AEFC06Q38565769-622DB218-C90B-43C2-B03B-2B8A600BBD38
P2860
Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Attenuation of Rhes activity s ...... model of Huntington's disease.
@ast
Attenuation of Rhes activity s ...... model of Huntington's disease.
@en
Attenuation of Rhes activity s ...... model of Huntington's disease.
@nl
type
label
Attenuation of Rhes activity s ...... model of Huntington's disease.
@ast
Attenuation of Rhes activity s ...... model of Huntington's disease.
@en
Attenuation of Rhes activity s ...... model of Huntington's disease.
@nl
prefLabel
Attenuation of Rhes activity s ...... model of Huntington's disease.
@ast
Attenuation of Rhes activity s ...... model of Huntington's disease.
@en
Attenuation of Rhes activity s ...... model of Huntington's disease.
@nl
P2093
P2860
P1433
P1476
Attenuation of Rhes activity s ...... model of Huntington's disease.
@en
P2093
Brandon A Baiamonte
Daniela Spano
Franklin A Lee
Gerald J LaHoste
Steve T Brewer
P2860
P304
P356
10.1371/JOURNAL.PONE.0053606
P407
P577
2013-01-21T00:00:00Z